MediciNova and Avigen Confirm Understanding for Key Terms for a Business Combination
MediciNova, Inc., a biopharmaceutical company that is publicly traded on the Nasdaq Global Market and the Hercules Market of the Osaka Securities Exchange, and Avigen, Inc. , a biopharmaceutical company, announced that they have confirmed their understanding of certain key terms for a proposed acquisition of Avigen by MediciNova that would combine the companies' broad neurological clinical development programs based on ibudilast. [more...]
|
|
|
